Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lunera Oy
OY
Active
Y-tunnus 2177356-3
Vankionkuja 20, 21410
Vanhalinna
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2008 · 18 years old
— employees
www.lunera.fi
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
Lunera Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2019
2020
2021
2024
2025
Revenue
131
74
74
60
48
Staff expenses
−3
—
−4
−2
−2
EBITDA
−5
27
14
8
0
Depreciation & amort.
—
—
—
−0
−0
EBIT
−5
27
14
8
0
Net financials
−1
−1
−1
−2
−1
Profit before tax
−5
26
13
6
−1
Tax
−0
−0
−0
−0
−0
Net profit
−5
26
13
6
−1
Balance sheet
EUR thousands
Item
2019
2020
2021
2024
2025
Total assets
61
57
35
22
15
Equity
−45
−29
−16
−67
−68
Long-term debt
52
41
13
62
60
Short-term debt
54
45
38
27
22
Total debt
106
86
51
89
82
Financial ratios
5-year trend
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
2019
2025
Equity ratio
-459.2%
This company
38.2%
Market median
-1302% vs market
2019
2025
Return on equity
-85000.0%
This company
18.4%
Market median
-462057% vs market
2019
2025
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
2019
2025
Asset turnover
3.24×
This company
1.12×
Market median
+189% vs market
2019
2025
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
2019
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
More on Lunera Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network